The anthelmintic praziquantel is a human serotoninergic G-protein-coupled receptor ligand

John D. Chan, Pauline M. Cupit, Gihan S. Gunaratne, John D. McCorvy, Yang Yang, Kristen Stoltz, Thomas R. Webb, Peter I. Dosa, Bryan L. Roth, Ruben Abagyan, Charles Cunningham, Jonathan S. Marchant

Research output: Contribution to journalArticlepeer-review

39 Scopus citations

Abstract

Schistosomiasis is a debilitating tropical disease caused by infection with parasitic blood flukes. Approximately 260 million people are infected worldwide, underscoring the clinical and socioeconomic impact of this chronic infection. Schistosomiasis is treated with the drug praziquantel (PZQ), which has proved the therapeutic mainstay for over three decades of clinical use. However, the molecular target(s) of PZQ remain undefined. Here we identify a molecular target for the antischistosomal eutomer-(R)-PZQ-which functions as a partial agonist of the human serotoninergic 5HT2B receptor. (R)-PZQ modulation of serotoninergic signaling occurs over a concentration range sufficient to regulate vascular tone of the mesenteric blood vessels where the adult parasites reside within their host. These data establish (R)-PZQ as a G-protein-coupled receptor ligand and suggest that the efficacy of this clinically important anthelmintic is supported by a broad, cross species polypharmacology with PZQ modulating signaling events in both host and parasite.

Original languageEnglish (US)
Article number1910
JournalNature communications
Volume8
Issue number1
DOIs
StatePublished - Dec 1 2017

Bibliographical note

Funding Information:
Schistosome-infected mice were provided by the NIAID Schistosomiasis Resource Center at the Biomedical Research Institute (Rockville, MD) through NIH-NIAID Contract HHSN272201000005I for distribution through BEI Resources. Work was supported by the NIH (GM088790, R21AI25821, R21AI130642 to J.S.M.; RO1MH61887 to J.D.M. and B.L.R.; R01AI087807 to C.C., T.R.W. and P.M.C.), NSF (MCB1615538 to J.S.M.) and the National Institute of Mental Health’s Psychoactive Drug Screening Program PDSP screening program, contract #HHSN-271-2013-00017-C (NIMH PDSP). We thank Joyce Lee, Nawal Yahya and Jonathan Wojcik for their assistance preparing this work.

Fingerprint Dive into the research topics of 'The anthelmintic praziquantel is a human serotoninergic G-protein-coupled receptor ligand'. Together they form a unique fingerprint.

Cite this